 in a
randomized, controlled trial. J Vasc Surg Venous Lymphat Disord
2021;9:286.
186. Nakano LC, Cacione DG, Baptista-Silva JC, Flumignan RL. Treatment
for telangiectasias and reticular veins. Cochrane Database Syst Rev
2021;10:Cd012723.
187. Meesters AA, Pitassi LH, Campos V, Wolkerstorfer A, Dierickx CC.
Transcutaneous laser treatment of leg veins. Lasers Med Sci 2014;29:
481-92.
188. Parlar B, Blazek C, Cazzaniga S, et al. Treatment of lower extremity
telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a
prospective, comparative, randomized, open-label trial. J Eur Acad
Dermatol Venereol 2015;29:549-54.
189. Passman M. Transilluminated powered phlebectomy in the treatment of varicose veins. Vascular 2007;15:262-8.
190. Passman MA, Dattilo JB, Guzman RJ, Naslund TC. Combined
endovenous ablation and transilluminated powered phlebectomy:
is less invasive better? Vasc Endovascular Surg 2007;41:41-7.
191. Lin PH, Matos JM, Chen A, et al. Treatment outcomes and lessons
learned from transilluminated powered phlebectomy for varicose
veins in 1034 patients. Vasc Endovascular Surg 2016;50:277-82.
192. Aremu MA, Mahendran B, Butcher W, et al. Prospective randomized
controlled trial: conventional versus powered phlebectomy. J Vasc
Surg 2004;39:88-94.
193. Chetter IC, Mylankal KJ, Hughes H, Fitridge R. Randomized clinical